Novadaq (NVDQ) Hit By Craig-Hallum Downgrade. Has $11.8000 Target, EPAZZ (EPAZ) Shorts Decreased By 71.43%

June 19, 2017 - By Vivian Park

Among 6 analysts covering Novadaq Technologies Inc (NASDAQ:NVDQ), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Novadaq Technologies Inc has $17 highest and $11 lowest target. $13.25’s average target is 13.25% above currents $11.7 stock price. Novadaq Technologies Inc had 9 analyst reports since October 7, 2015 according to SRatingsIntel. First Analysis upgraded Novadaq Technologies Inc. (NASDAQ:NVDQ) rating on Thursday, October 29. First Analysis has “Overweight” rating and $15 target. As per Wednesday, January 11, the company rating was downgraded by William Blair. The stock of Novadaq Technologies Inc. (NASDAQ:NVDQ) earned “Mkt Outperform” rating by JMP Securities on Wednesday, January 6. The rating was initiated by Wedbush on Wednesday, October 7 with “Outperform”. The rating was maintained by Wedbush with “Outperform” on Wednesday, January 11. The rating was maintained by RBC Capital Markets on Wednesday, January 11 with “Outperform”.

EPAZZ INCORPORATED (OTCMKTS:EPAZ) had a decrease of 71.43% in short interest. EPAZ’s SI was 3,200 shares in June as released by FINRA. Its down 71.43% from 11,200 shares previously. About 57,806 shares traded or 49.05% up from the average. Epazz Inc (OTCMKTS:EPAZ) has 0.00% since June 19, 2016 and is . It has underperformed by 16.70% the S&P500.

The stock increased 95.00% or $5.7 during the last trading session, reaching $11.7. About 25.20 million shares traded or 11876.96% up from the average. Novadaq Technologies Inc. (NASDAQ:NVDQ) has declined 24.90% since June 19, 2016 and is downtrending. It has underperformed by 41.60% the S&P500.

Analysts await Novadaq Technologies Inc. (NASDAQ:NVDQ) to report earnings on July, 26. They expect $-0.21 EPS, up 27.59% or $0.08 from last year’s $-0.29 per share. After $-0.24 actual EPS reported by Novadaq Technologies Inc. for the previous quarter, Wall Street now forecasts -12.50% EPS growth.

NOVADAQ Technologies Inc. is a medical device company. The company has market cap of $346.82 million. The Firm primarily develops, makes and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed. It currently has negative earnings. The Company’s SPY fluorescence imaging technology platform provides clinically relevant anatomic and physiologic images of blood flow in vessels and micro-vessels during a range of surgical and outpatient procedures performed in the operating room or clinic.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: